In the rapidly evolving realm of advanced therapy medicinal products (ATMPs) and complex biologics, the promise of transforming patient care is both exhilarating and daunting, as these cutting-edge treatments hold the potential to address some of the most pressing unmet medical needs, from rare
We’re sitting down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research, development, and cutting-edge technology within the industry. With a career dedicated to pushing the boundaries of innovation, Ivan offers a unique perspective on how science and tech intersect
In a landmark effort to strengthen health security across Southeast Asia, Australia and Thailand have embarked on a transformative partnership that promises to reshape the region’s approach to public health, bringing new hope for resilience. Announced on August 11, this collaboration brings
In a landscape where over 50% of pharmaceuticals distributed in the US are manufactured overseas, the fragility of the drug supply chain has become a pressing concern for national health security, prompting urgent action. Imagine a scenario where a global crisis disrupts access to essential
In a landscape where economic volatility often shakes investor confidence, Becton Dickinson (BDX) has emerged as a standout performer, recently revising its full-year earnings outlook upward with an adjusted diluted EPS guidance of $14.30 to $14.45, reflecting a robust 9.4% growth at the midpoint.
The pharmaceutical industry stands on the brink of a technological revolution with the recent release of the Good Automated Manufacturing Practice (GAMP) Artificial Intelligence Guide by the International Society for Pharmaceutical Engineering (ISPE). As pharmaceutical companies increasingly turn
